• Thursday, Aug 11, 2022
  • Last Update : 04:24 pm

US wants to produce its Covid-19 vaccines in Bangladesh

  • Published at 07:49 pm May 17th, 2021
​​​​File photo: A vial of AstraZeneca Covid-19 vaccine is seen at a vaccination center, amid the coronavirus disease outbreak, in Ronquieres, Belgium April 6, 2021_ Reuters
​​​​File photo of a vial of AstraZeneca Covid-19 vaccine Reuters

Washington yet to make any decision on providing Dhaka with share of 60m vaccine jabs, says US embassy in Dhak

The US government is exploring possibilities of producing its Covid-19 vaccines at Bangladeshi pharmaceutical companies.

At a meeting with State Minister for Foreign Affairs Shahriar Alam on Monday, US Ambassador to Bangladesh Earl R Miller discussed the matter, said the Foreign Ministry without giving any more details.

Meanwhile, the US government has yet to make any decision with respect to the share of 60 million Covid-19 vaccines Bangladesh might get.

“The embassy is working closely with the Department of State, USAID, DOD (Department of Defense), NSC (National Security Council), other government agencies and the private sector to determine how best to further support Bangladesh in fighting Covid,” a spokesperson for the US embassy in Dhaka told Dhaka Tribune when asked if Bangladesh would get any share of the 60 million vaccines and, if it did, when and what would be the quantity.


Also Read - Vaccine delivery: Miller says US actively considering Bangladesh’s request


Bangladesh has already placed a request with the US for a share of the vaccines. 

Since the start of the outbreak, the US government has provided Bangladesh over $76 million in Covid response assistance, said the spokesperson.       

At the meeting on Monday, State Minister Alam and Ambassador Miller also discussed ongoing Dhaka-Washington cooperation in combating the Covid-19 pandemic, including the issue of a provision of vaccines to meet Bangladesh’s immediate needs.

The ambassador informed the state minister that his government was working on the matter, and that he had recommended a regional approach in South Asia in a distribution of vaccines from the US.